US$ 25.71
ipamorelin minimal cortisol prolactin – SQRL PEPTIDE LABS The Involvement of Prolactin in
Description
37 HalievskiK.XuY.HaddadY.TangY.YamadaS.KatsunoM.et al (2020)

Mid-range doses (10-20mg) showed optimal efficacy-to-safety ratio Phase III: ~500 subjects, 24 weeks, failed to reach primary endpoint (statistically significant weight loss vs placebo at 24 weeks)

No evidence of substantial heterogeneity in this meta-analysis was found

Biochim Biophys Acta Mol Cell Res 1868(2):118913
